Is alglucosidase alfa (Myozyme/Lumizyme) available as a generic?
“Alglucosidase alfa” is the enzyme replacement therapy used for late-onset and infantile-onset Pompe disease. There is no approved generic version of the specific biologic “alglucosidase alfa” in the information provided here.
What is approved and sold can vary by country because biologics and follow-on versions are regulated differently across jurisdictions. In many places, the practical question is whether an approved “biosimilar” or “follow-on” enzyme exists rather than a true generic small-molecule drug.
What you should ask for instead: biosimilar or follow-on enzyme (not a small-molecule generic)
Alglucosidase alfa is a biologic enzyme product, so a replacement is usually discussed as:
- a biosimilar (when regulators deem it highly similar to the reference product), or
- a “follow-on” biologic/follow-on enzyme (depending on the country’s regulatory pathway).
If you are trying to switch to a cheaper alternative, the right term to use with prescribers and pharmacies is “biosimilar” or “follow-on alglucosidase alfa” in your country.
What changes when patients switch products (reference vs biosimilar/follow-on)
Even when an approved follow-on exists, switches can involve:
- updated prescribing/dispensing of the new product name,
- monitoring for safety and effectiveness (including antibody/immune response where applicable),
- potential differences in infusion logistics or support programs.
Clinicians often individualize switching decisions for Pompe disease because enzyme products can affect immunogenicity and clinical response over time.
How to check if a biosimilar exists where you live
Search using your country’s regulator plus the drug name, for example:
- “alglucosidase alfa biosimilar approval [country regulator name]”
- “Pompe disease alglucosidase alfa follow-on”
If you tell me your country (or the brand you currently use: Myozyme or Lumizyme), I can help narrow down what name(s) to look for and how approvals are typically labeled there.
Why “generic” wording is confusing for enzyme replacement therapies
People often say “generic biologic” as shorthand, but regulators generally do not treat biologics the same way as traditional chemical generics. So “generic alglucosidase alfa” may not be the precise label you will see, even if an approved alternative exists.
---
Sources
No sources were provided in the prompt, so I can’t verify approval status or availability for specific countries. If you share your country and whether you mean Myozyme or Lumizyme, I can tailor the answer to the exact products and terminology used there.